Nouvelle déclaration d'incident
No de la demande: 2010-5260
Numéro de référence du titulaire d'homologation: SC692734
Nom du titulaire (nom légal complet, aucune abbréviation): Dow AgroSciences Canada Inc.
Adresse: 450-1st Street SW, Suite 2100
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2P 5H1
Incident chez l'humain
Pays: UNITED STATES
État: OKLAHOMA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 62719-182
Nom du produit: Grazon P+D Herbicide
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 62719-182
Nom du produit: Remedy Ultra Herbicide
Liquide
Oui
Inconnu
Site: Agricultural-Outdoor/Agricole-extérieur
Specify Type: Unknown
Personne affectée
Sexe: Homme
Âge: >64 yrs / > 64 ans
Système
>2 mos and <=6mos />2 mois et <=6mois
Oui
Oui
45
Day(s) / Jour(s)
Professionnel
Application
Aucun
Inconnu
<=15 min / <=15 min
>8 hrs <=24 hrs / > 8 h < = 24 h
9/15/2010 1:37:46 PM Caller states that he sprayed about 800 acres with Grazon 05/18/2010 and he was hospitalized with chemical pneumonia and thrombocytopenia from 05/19/2010 until 07/01/2010. He is unable to recount any specific instance of exposure or spray drift. He was not wearing personal protective equipment. He assumes the exposure somehow occurred by virtue of his being the applicator. He had a bone marrow test done in July 2010. Caller was diagnosed with myleodysplasia syndrome that caller states is turning into Leukemia. The doctor's have not indicated that the Grazon was the cause of his cancer. Caller relayed that in addition to the Grazon, he used Remedy Ultra and 2,4-D while spraying. The spraying was done for a neighbor. He is not a licensed applicator and he did not use personal protective equipment while spraying. He was just able to find out what he sprayed with yesterday and he is calling to report this incident. He has declined chemotherapy at this time.
Majeure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. When considering the body of regulatory data as well as the weight of scientific peer reviewed evidence involving the contents of this pesticide, any relationship between the single acute use of this product and the development of cancer/neoplasia is inconceivable and lacks any biological plausibility. First, the ingredients are not known to be carcinogenic at application concentrations following a single application, but more importantly, the type of physiological abnormality described with regard to this patient's diagnosed disease is chronic in its development where several months to years are required before overt clinical signs and symptoms become manifest.